AstraZeneca Closes Amyloidosis Gap On Alnylam After Eplontersen Win

Positive Phase III For Ionis-Partnered Antisense Candidate

 
• By Kevin Grogan
Sodertalje, Sweden - April 27, 2014: Three purple flags with the logo for Atrazeneca flying in the wind on top of the flagpoles against the blue sky.
• Source: Archive

More from Clinical Trials

More from R&D